Atrophic gastritis, polyp, adenoma
Conditions
Interventions
control group:Nothing
Experimental group:Applied AI products
Software independent judgment result group:Perform software independent diagnosis
Expert diagnosis result group:Independent evaluation by third-party experts
Sponsors
Beijing Friendship Hospital,Capital Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Age is 18 years or older, male or female; 2) Subjects with gastric or colonoscopy diagnosis and screening needs; 3) Sign a written informed consent.
Exclusion criteria
Exclusion criteria: 1) Past history of acute myocardial infarction, severe cardiac, hepatic and renal insufficiency, or mental illness. 2) Those who are taking anticoagulants such as aspirin and warfarin. 3) Re-examination of inflammatory bowel disease and polyposis; 4) Subjects with a history of gastrectomy or colon resection; 5) Patients with familial polyposis; 6) Subjects that the researcher thinks are not suitable to participate in this clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sensitivity and specificity of polyps detection;Detection rate of atrophic gastritis, polyps and adenomas; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity and specificity of identification of polyps in software;Detection rate of atrophic gastritis and adenoma in software group; | — |
Countries
China
Contacts
Public ContactZhu Shengtao
Beijing Friendship Hospital,Capital Medical University
Outcome results
None listed